- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/424 - Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
Patent holdings for IPC class A61K 31/424
Total number of patents in this class: 415
10-year publication summary
|
35
|
31
|
42
|
34
|
27
|
36
|
24
|
23
|
24
|
10
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3739 |
16 |
| F. Hoffmann-La Roche AG | 7920 |
7 |
| Theriva Biologics, Inc. | 83 |
7 |
| Novartis AG | 10927 |
6 |
| Hoffmann-La Roche Inc. | 3369 |
6 |
| Merck Sharp & Dohme Corp. | 2201 |
6 |
| Janssen Pharmaceutica N.V. | 3432 |
6 |
| Takeda Pharmaceutical Company Limited | 2703 |
6 |
| Constellation Pharmaceuticals, Inc. | 210 |
6 |
| Ovid Therapeutics Inc | 154 |
6 |
| Council of Scientific & Industrial Research | 1418 |
5 |
| Bristol-myers Squibb Company | 4897 |
4 |
| Genentech, Inc. | 3954 |
4 |
| Boehringer Ingelheim International GmbH | 4701 |
4 |
| Centre for Digestive Diseases | 17 |
4 |
| Japan Tobacco Inc. | 3508 |
4 |
| Otsuka Pharmaceutical Co., Ltd. | 1499 |
4 |
| Taisho Pharmaceutical Co., Ltd. | 859 |
4 |
| Amgen Inc. | 4037 |
3 |
| Glaxosmithkline Intellectual Property Development Limited | 753 |
3 |
| Other owners | 304 |